nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—KCNJ11—mammary gland—breast cancer	0.0146	0.0781	CbGeAlD
Levosimendan—TNNC1—endometrium—breast cancer	0.0119	0.0638	CbGeAlD
Levosimendan—TNNC1—pituitary gland—breast cancer	0.0108	0.0577	CbGeAlD
Levosimendan—TNNC1—adipose tissue—breast cancer	0.0108	0.0575	CbGeAlD
Levosimendan—TNNC1—adrenal gland—breast cancer	0.00965	0.0516	CbGeAlD
Levosimendan—KCNJ8—endometrium—breast cancer	0.00895	0.0479	CbGeAlD
Levosimendan—KCNJ8—uterus—breast cancer	0.00825	0.0441	CbGeAlD
Levosimendan—KCNJ8—pituitary gland—breast cancer	0.0081	0.0433	CbGeAlD
Levosimendan—KCNJ8—adipose tissue—breast cancer	0.00807	0.0432	CbGeAlD
Levosimendan—KCNJ8—female reproductive system—breast cancer	0.00742	0.0397	CbGeAlD
Levosimendan—KCNJ8—adrenal gland—breast cancer	0.00724	0.0387	CbGeAlD
Levosimendan—KCNJ8—female gonad—breast cancer	0.00675	0.0361	CbGeAlD
Levosimendan—PDE3A—adipose tissue—breast cancer	0.00644	0.0344	CbGeAlD
Levosimendan—KCNJ8—endocrine gland—breast cancer	0.00628	0.0336	CbGeAlD
Levosimendan—KCNJ11—female reproductive system—breast cancer	0.00604	0.0323	CbGeAlD
Levosimendan—PDE3A—female reproductive system—breast cancer	0.00592	0.0317	CbGeAlD
Levosimendan—KCNJ11—adrenal gland—breast cancer	0.0059	0.0315	CbGeAlD
Levosimendan—TNNC1—lymph node—breast cancer	0.00578	0.0309	CbGeAlD
Levosimendan—PDE3A—adrenal gland—breast cancer	0.00578	0.0309	CbGeAlD
Levosimendan—KCNJ11—female gonad—breast cancer	0.0055	0.0294	CbGeAlD
Levosimendan—PDE3A—female gonad—breast cancer	0.00539	0.0288	CbGeAlD
Levosimendan—KCNJ11—endocrine gland—breast cancer	0.00511	0.0274	CbGeAlD
Levosimendan—PDE3A—endocrine gland—breast cancer	0.00501	0.0268	CbGeAlD
Levosimendan—KCNJ8—lymph node—breast cancer	0.00434	0.0232	CbGeAlD
Levosimendan—KCNJ11—lymph node—breast cancer	0.00354	0.0189	CbGeAlD
Levosimendan—PDE3A—lymph node—breast cancer	0.00346	0.0185	CbGeAlD
Levosimendan—Insomnia—Raloxifene—breast cancer	0.00197	0.00342	CcSEcCtD
Levosimendan—Dizziness—Fulvestrant—breast cancer	0.00197	0.00341	CcSEcCtD
Levosimendan—Constipation—Anastrozole—breast cancer	0.00197	0.0034	CcSEcCtD
Levosimendan—Constipation—Letrozole—breast cancer	0.00197	0.0034	CcSEcCtD
Levosimendan—Cardiac disorder—Goserelin—breast cancer	0.00196	0.0034	CcSEcCtD
Levosimendan—Dizziness—Toremifene—breast cancer	0.00194	0.00337	CcSEcCtD
Levosimendan—Atrial fibrillation—Paclitaxel—breast cancer	0.00194	0.00336	CcSEcCtD
Levosimendan—Nausea—Lapatinib—breast cancer	0.00192	0.00333	CcSEcCtD
Levosimendan—Angiopathy—Goserelin—breast cancer	0.00192	0.00332	CcSEcCtD
Levosimendan—Vomiting—Fulvestrant—breast cancer	0.00189	0.00328	CcSEcCtD
Levosimendan—Cardiac failure—Paclitaxel—breast cancer	0.00189	0.00327	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Raloxifene—breast cancer	0.00188	0.00326	CcSEcCtD
Levosimendan—Vomiting—Toremifene—breast cancer	0.00187	0.00324	CcSEcCtD
Levosimendan—Headache—Fulvestrant—breast cancer	0.00187	0.00323	CcSEcCtD
Levosimendan—Mental disorder—Goserelin—breast cancer	0.00185	0.00321	CcSEcCtD
Levosimendan—Headache—Toremifene—breast cancer	0.00184	0.00319	CcSEcCtD
Levosimendan—Malnutrition—Goserelin—breast cancer	0.00184	0.00319	CcSEcCtD
Levosimendan—Diarrhoea—Exemestane—breast cancer	0.00177	0.00306	CcSEcCtD
Levosimendan—Nausea—Fulvestrant—breast cancer	0.00177	0.00306	CcSEcCtD
Levosimendan—Cardiac disorder—Vinorelbine—breast cancer	0.00176	0.00304	CcSEcCtD
Levosimendan—Nausea—Toremifene—breast cancer	0.00175	0.00302	CcSEcCtD
Levosimendan—Angiopathy—Vinorelbine—breast cancer	0.00172	0.00298	CcSEcCtD
Levosimendan—Dizziness—Exemestane—breast cancer	0.00171	0.00296	CcSEcCtD
Levosimendan—Cardiac disorder—Thiotepa—breast cancer	0.00168	0.00291	CcSEcCtD
Levosimendan—Hypokalaemia—Paclitaxel—breast cancer	0.00168	0.0029	CcSEcCtD
Levosimendan—Diarrhoea—Ixabepilone—breast cancer	0.00167	0.00289	CcSEcCtD
Levosimendan—Malnutrition—Vinorelbine—breast cancer	0.00165	0.00285	CcSEcCtD
Levosimendan—Atrial fibrillation—Docetaxel—breast cancer	0.00165	0.00285	CcSEcCtD
Levosimendan—Vomiting—Exemestane—breast cancer	0.00165	0.00285	CcSEcCtD
Levosimendan—Angiopathy—Thiotepa—breast cancer	0.00164	0.00284	CcSEcCtD
Levosimendan—Headache—Exemestane—breast cancer	0.00162	0.00281	CcSEcCtD
Levosimendan—Dizziness—Ixabepilone—breast cancer	0.00161	0.00279	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Epirubicin—breast cancer	0.00161	0.00278	CcSEcCtD
Levosimendan—Cardiac failure—Docetaxel—breast cancer	0.0016	0.00277	CcSEcCtD
Levosimendan—Atrial fibrillation—Capecitabine—breast cancer	0.0016	0.00276	CcSEcCtD
Levosimendan—Mental disorder—Thiotepa—breast cancer	0.00159	0.00274	CcSEcCtD
Levosimendan—Malnutrition—Thiotepa—breast cancer	0.00158	0.00273	CcSEcCtD
Levosimendan—Diarrhoea—Letrozole—breast cancer	0.00157	0.00272	CcSEcCtD
Levosimendan—Diarrhoea—Anastrozole—breast cancer	0.00157	0.00272	CcSEcCtD
Levosimendan—Vomiting—Ixabepilone—breast cancer	0.00155	0.00269	CcSEcCtD
Levosimendan—Cardiac failure—Capecitabine—breast cancer	0.00155	0.00268	CcSEcCtD
Levosimendan—Nausea—Exemestane—breast cancer	0.00154	0.00266	CcSEcCtD
Levosimendan—Headache—Ixabepilone—breast cancer	0.00153	0.00265	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Chlorambucil—breast cancer	0.00153	0.00264	CcSEcCtD
Levosimendan—Dizziness—Letrozole—breast cancer	0.00152	0.00263	CcSEcCtD
Levosimendan—Dizziness—Anastrozole—breast cancer	0.00152	0.00263	CcSEcCtD
Levosimendan—Tachycardia—Melphalan—breast cancer	0.0015	0.0026	CcSEcCtD
Levosimendan—Diarrhoea—Raloxifene—breast cancer	0.00149	0.00258	CcSEcCtD
Levosimendan—Diarrhoea—Idarubicin—breast cancer	0.00149	0.00258	CcSEcCtD
Levosimendan—Ventricular extrasystoles—Doxorubicin—breast cancer	0.00149	0.00257	CcSEcCtD
Levosimendan—Nervous system disorder—Goserelin—breast cancer	0.00147	0.00255	CcSEcCtD
Levosimendan—Tachycardia—Goserelin—breast cancer	0.00147	0.00254	CcSEcCtD
Levosimendan—Vomiting—Letrozole—breast cancer	0.00146	0.00253	CcSEcCtD
Levosimendan—Vomiting—Anastrozole—breast cancer	0.00146	0.00253	CcSEcCtD
Levosimendan—Ventricular tachycardia—Epirubicin—breast cancer	0.00145	0.00251	CcSEcCtD
Levosimendan—Nausea—Ixabepilone—breast cancer	0.00145	0.00251	CcSEcCtD
Levosimendan—Cardiac disorder—Irinotecan—breast cancer	0.00145	0.00251	CcSEcCtD
Levosimendan—Dizziness—Raloxifene—breast cancer	0.00144	0.0025	CcSEcCtD
Levosimendan—Headache—Letrozole—breast cancer	0.00144	0.00249	CcSEcCtD
Levosimendan—Headache—Anastrozole—breast cancer	0.00144	0.00249	CcSEcCtD
Levosimendan—Hypotension—Melphalan—breast cancer	0.00144	0.00249	CcSEcCtD
Levosimendan—Insomnia—Tamoxifen—breast cancer	0.00142	0.00246	CcSEcCtD
Levosimendan—Angiopathy—Irinotecan—breast cancer	0.00142	0.00245	CcSEcCtD
Levosimendan—Cardiac disorder—Gemcitabine—breast cancer	0.00141	0.00244	CcSEcCtD
Levosimendan—Hypotension—Goserelin—breast cancer	0.0014	0.00243	CcSEcCtD
Levosimendan—Vomiting—Idarubicin—breast cancer	0.00139	0.0024	CcSEcCtD
Levosimendan—Vomiting—Raloxifene—breast cancer	0.00139	0.0024	CcSEcCtD
Levosimendan—Constipation—Vinblastine—breast cancer	0.00139	0.0024	CcSEcCtD
Levosimendan—Angiopathy—Gemcitabine—breast cancer	0.00138	0.00239	CcSEcCtD
Levosimendan—Hypokalaemia—Capecitabine—breast cancer	0.00138	0.00238	CcSEcCtD
Levosimendan—Headache—Raloxifene—breast cancer	0.00137	0.00237	CcSEcCtD
Levosimendan—Headache—Idarubicin—breast cancer	0.00137	0.00237	CcSEcCtD
Levosimendan—Nausea—Letrozole—breast cancer	0.00137	0.00236	CcSEcCtD
Levosimendan—Nausea—Anastrozole—breast cancer	0.00137	0.00236	CcSEcCtD
Levosimendan—Insomnia—Goserelin—breast cancer	0.00136	0.00235	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Tamoxifen—breast cancer	0.00136	0.00235	CcSEcCtD
Levosimendan—Constipation—Tamoxifen—breast cancer	0.00135	0.00233	CcSEcCtD
Levosimendan—Ventricular tachycardia—Doxorubicin—breast cancer	0.00134	0.00232	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Melphalan—breast cancer	0.00133	0.0023	CcSEcCtD
Levosimendan—Nervous system disorder—Vinorelbine—breast cancer	0.00132	0.00228	CcSEcCtD
Levosimendan—Tachycardia—Vinorelbine—breast cancer	0.00131	0.00227	CcSEcCtD
Levosimendan—Nausea—Raloxifene—breast cancer	0.0013	0.00224	CcSEcCtD
Levosimendan—Nausea—Idarubicin—breast cancer	0.0013	0.00224	CcSEcCtD
Levosimendan—Constipation—Goserelin—breast cancer	0.00129	0.00222	CcSEcCtD
Levosimendan—Nervous system disorder—Thiotepa—breast cancer	0.00126	0.00218	CcSEcCtD
Levosimendan—Hypotension—Vinorelbine—breast cancer	0.00126	0.00218	CcSEcCtD
Levosimendan—Tachycardia—Thiotepa—breast cancer	0.00125	0.00217	CcSEcCtD
Levosimendan—Diarrhoea—Chlorambucil—breast cancer	0.00121	0.00209	CcSEcCtD
Levosimendan—Cardiac disorder—Paclitaxel—breast cancer	0.00118	0.00205	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Vinorelbine—breast cancer	0.00116	0.00201	CcSEcCtD
Levosimendan—Angiopathy—Paclitaxel—breast cancer	0.00116	0.002	CcSEcCtD
Levosimendan—Constipation—Vinorelbine—breast cancer	0.00115	0.00199	CcSEcCtD
Levosimendan—Vomiting—Chlorambucil—breast cancer	0.00112	0.00195	CcSEcCtD
Levosimendan—Mental disorder—Paclitaxel—breast cancer	0.00112	0.00193	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Thiotepa—breast cancer	0.00111	0.00192	CcSEcCtD
Levosimendan—Malnutrition—Paclitaxel—breast cancer	0.00111	0.00192	CcSEcCtD
Levosimendan—Diarrhoea—Vinblastine—breast cancer	0.00111	0.00192	CcSEcCtD
Levosimendan—Constipation—Thiotepa—breast cancer	0.0011	0.0019	CcSEcCtD
Levosimendan—Nervous system disorder—Irinotecan—breast cancer	0.00109	0.00188	CcSEcCtD
Levosimendan—Tachycardia—Mitoxantrone—breast cancer	0.00108	0.00188	CcSEcCtD
Levosimendan—Cardiac failure—Epirubicin—breast cancer	0.00108	0.00187	CcSEcCtD
Levosimendan—Diarrhoea—Tamoxifen—breast cancer	0.00108	0.00186	CcSEcCtD
Levosimendan—Dizziness—Vinblastine—breast cancer	0.00107	0.00185	CcSEcCtD
Levosimendan—Nervous system disorder—Gemcitabine—breast cancer	0.00106	0.00184	CcSEcCtD
Levosimendan—Diarrhoea—Melphalan—breast cancer	0.00105	0.00182	CcSEcCtD
Levosimendan—Nausea—Chlorambucil—breast cancer	0.00105	0.00182	CcSEcCtD
Levosimendan—Nervous system disorder—Fluorouracil—breast cancer	0.00104	0.0018	CcSEcCtD
Levosimendan—Dizziness—Tamoxifen—breast cancer	0.00104	0.0018	CcSEcCtD
Levosimendan—Tachycardia—Fluorouracil—breast cancer	0.00104	0.0018	CcSEcCtD
Levosimendan—Hypotension—Irinotecan—breast cancer	0.00104	0.0018	CcSEcCtD
Levosimendan—Hypotension—Mitoxantrone—breast cancer	0.00104	0.0018	CcSEcCtD
Levosimendan—Vomiting—Vinblastine—breast cancer	0.00103	0.00178	CcSEcCtD
Levosimendan—Diarrhoea—Goserelin—breast cancer	0.00103	0.00178	CcSEcCtD
Levosimendan—Headache—Vinblastine—breast cancer	0.00101	0.00176	CcSEcCtD
Levosimendan—Hypotension—Gemcitabine—breast cancer	0.00101	0.00175	CcSEcCtD
Levosimendan—Insomnia—Irinotecan—breast cancer	0.001	0.00174	CcSEcCtD
Levosimendan—Cardiac disorder—Docetaxel—breast cancer	0.001	0.00174	CcSEcCtD
Levosimendan—Vomiting—Tamoxifen—breast cancer	0.001	0.00173	CcSEcCtD
Levosimendan—Cardiac failure—Doxorubicin—breast cancer	0.000999	0.00173	CcSEcCtD
Levosimendan—Dizziness—Goserelin—breast cancer	0.000994	0.00172	CcSEcCtD
Levosimendan—Hypotension—Fluorouracil—breast cancer	0.000994	0.00172	CcSEcCtD
Levosimendan—Headache—Tamoxifen—breast cancer	0.000986	0.00171	CcSEcCtD
Levosimendan—Angiopathy—Docetaxel—breast cancer	0.00098	0.0017	CcSEcCtD
Levosimendan—Vomiting—Melphalan—breast cancer	0.00098	0.0017	CcSEcCtD
Levosimendan—Insomnia—Gemcitabine—breast cancer	0.000978	0.00169	CcSEcCtD
Levosimendan—Cardiac disorder—Capecitabine—breast cancer	0.000971	0.00168	CcSEcCtD
Levosimendan—Nausea—Vinblastine—breast cancer	0.000962	0.00167	CcSEcCtD
Levosimendan—Insomnia—Fluorouracil—breast cancer	0.000962	0.00166	CcSEcCtD
Levosimendan—Hypokalaemia—Epirubicin—breast cancer	0.000959	0.00166	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Irinotecan—breast cancer	0.000959	0.00166	CcSEcCtD
Levosimendan—Vomiting—Goserelin—breast cancer	0.000956	0.00165	CcSEcCtD
Levosimendan—Constipation—Mitoxantrone—breast cancer	0.000949	0.00164	CcSEcCtD
Levosimendan—Constipation—Irinotecan—breast cancer	0.000949	0.00164	CcSEcCtD
Levosimendan—Angiopathy—Capecitabine—breast cancer	0.000949	0.00164	CcSEcCtD
Levosimendan—Mental disorder—Docetaxel—breast cancer	0.000946	0.00164	CcSEcCtD
Levosimendan—Headache—Goserelin—breast cancer	0.000942	0.00163	CcSEcCtD
Levosimendan—Malnutrition—Docetaxel—breast cancer	0.00094	0.00163	CcSEcCtD
Levosimendan—Nausea—Tamoxifen—breast cancer	0.000935	0.00162	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000934	0.00162	CcSEcCtD
Levosimendan—Constipation—Gemcitabine—breast cancer	0.000925	0.0016	CcSEcCtD
Levosimendan—Diarrhoea—Vinorelbine—breast cancer	0.000921	0.00159	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000918	0.00159	CcSEcCtD
Levosimendan—Mental disorder—Capecitabine—breast cancer	0.000916	0.00159	CcSEcCtD
Levosimendan—Nausea—Melphalan—breast cancer	0.000915	0.00158	CcSEcCtD
Levosimendan—Malnutrition—Capecitabine—breast cancer	0.00091	0.00158	CcSEcCtD
Levosimendan—Nausea—Goserelin—breast cancer	0.000893	0.00155	CcSEcCtD
Levosimendan—Dizziness—Vinorelbine—breast cancer	0.00089	0.00154	CcSEcCtD
Levosimendan—Nervous system disorder—Paclitaxel—breast cancer	0.000888	0.00154	CcSEcCtD
Levosimendan—Hypokalaemia—Doxorubicin—breast cancer	0.000887	0.00153	CcSEcCtD
Levosimendan—Tachycardia—Paclitaxel—breast cancer	0.000884	0.00153	CcSEcCtD
Levosimendan—Diarrhoea—Thiotepa—breast cancer	0.00088	0.00152	CcSEcCtD
Levosimendan—Vomiting—Vinorelbine—breast cancer	0.000856	0.00148	CcSEcCtD
Levosimendan—Dizziness—Thiotepa—breast cancer	0.00085	0.00147	CcSEcCtD
Levosimendan—Hypotension—Paclitaxel—breast cancer	0.000846	0.00146	CcSEcCtD
Levosimendan—Headache—Vinorelbine—breast cancer	0.000843	0.00146	CcSEcCtD
Levosimendan—Insomnia—Paclitaxel—breast cancer	0.000819	0.00142	CcSEcCtD
Levosimendan—Vomiting—Thiotepa—breast cancer	0.000817	0.00141	CcSEcCtD
Levosimendan—Headache—Thiotepa—breast cancer	0.000805	0.00139	CcSEcCtD
Levosimendan—Nausea—Vinorelbine—breast cancer	0.0008	0.00138	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000782	0.00135	CcSEcCtD
Levosimendan—Constipation—Paclitaxel—breast cancer	0.000774	0.00134	CcSEcCtD
Levosimendan—Nausea—Thiotepa—breast cancer	0.000764	0.00132	CcSEcCtD
Levosimendan—Diarrhoea—Irinotecan—breast cancer	0.00076	0.00131	CcSEcCtD
Levosimendan—Diarrhoea—Mitoxantrone—breast cancer	0.00076	0.00131	CcSEcCtD
Levosimendan—Nervous system disorder—Docetaxel—breast cancer	0.000753	0.0013	CcSEcCtD
Levosimendan—Tachycardia—Docetaxel—breast cancer	0.000749	0.0013	CcSEcCtD
Levosimendan—Diarrhoea—Gemcitabine—breast cancer	0.00074	0.00128	CcSEcCtD
Levosimendan—Dizziness—Irinotecan—breast cancer	0.000734	0.00127	CcSEcCtD
Levosimendan—Nervous system disorder—Capecitabine—breast cancer	0.000729	0.00126	CcSEcCtD
Levosimendan—Diarrhoea—Fluorouracil—breast cancer	0.000728	0.00126	CcSEcCtD
Levosimendan—Tachycardia—Capecitabine—breast cancer	0.000725	0.00126	CcSEcCtD
Levosimendan—Cardiac disorder—Methotrexate—breast cancer	0.000723	0.00125	CcSEcCtD
Levosimendan—Hypotension—Docetaxel—breast cancer	0.000717	0.00124	CcSEcCtD
Levosimendan—Angiopathy—Methotrexate—breast cancer	0.000706	0.00122	CcSEcCtD
Levosimendan—Vomiting—Irinotecan—breast cancer	0.000706	0.00122	CcSEcCtD
Levosimendan—Vomiting—Mitoxantrone—breast cancer	0.000706	0.00122	CcSEcCtD
Levosimendan—Dizziness—Fluorouracil—breast cancer	0.000703	0.00122	CcSEcCtD
Levosimendan—Headache—Irinotecan—breast cancer	0.000696	0.0012	CcSEcCtD
Levosimendan—Headache—Mitoxantrone—breast cancer	0.000696	0.0012	CcSEcCtD
Levosimendan—Hypotension—Capecitabine—breast cancer	0.000694	0.0012	CcSEcCtD
Levosimendan—Insomnia—Docetaxel—breast cancer	0.000694	0.0012	CcSEcCtD
Levosimendan—Vomiting—Gemcitabine—breast cancer	0.000688	0.00119	CcSEcCtD
Levosimendan—Mental disorder—Methotrexate—breast cancer	0.000682	0.00118	CcSEcCtD
Levosimendan—Malnutrition—Methotrexate—breast cancer	0.000678	0.00117	CcSEcCtD
Levosimendan—Headache—Gemcitabine—breast cancer	0.000678	0.00117	CcSEcCtD
Levosimendan—Cardiac disorder—Epirubicin—breast cancer	0.000676	0.00117	CcSEcCtD
Levosimendan—Vomiting—Fluorouracil—breast cancer	0.000676	0.00117	CcSEcCtD
Levosimendan—Insomnia—Capecitabine—breast cancer	0.000672	0.00116	CcSEcCtD
Levosimendan—Headache—Fluorouracil—breast cancer	0.000666	0.00115	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Docetaxel—breast cancer	0.000663	0.00115	CcSEcCtD
Levosimendan—Angiopathy—Epirubicin—breast cancer	0.000661	0.00114	CcSEcCtD
Levosimendan—Nausea—Mitoxantrone—breast cancer	0.000659	0.00114	CcSEcCtD
Levosimendan—Nausea—Irinotecan—breast cancer	0.000659	0.00114	CcSEcCtD
Levosimendan—Constipation—Docetaxel—breast cancer	0.000656	0.00114	CcSEcCtD
Levosimendan—Nausea—Gemcitabine—breast cancer	0.000642	0.00111	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Capecitabine—breast cancer	0.000642	0.00111	CcSEcCtD
Levosimendan—Mental disorder—Epirubicin—breast cancer	0.000638	0.0011	CcSEcCtD
Levosimendan—Constipation—Capecitabine—breast cancer	0.000635	0.0011	CcSEcCtD
Levosimendan—Malnutrition—Epirubicin—breast cancer	0.000634	0.0011	CcSEcCtD
Levosimendan—Nausea—Fluorouracil—breast cancer	0.000632	0.00109	CcSEcCtD
Levosimendan—Cardiac disorder—Doxorubicin—breast cancer	0.000626	0.00108	CcSEcCtD
Levosimendan—Diarrhoea—Paclitaxel—breast cancer	0.00062	0.00107	CcSEcCtD
Levosimendan—Angiopathy—Doxorubicin—breast cancer	0.000612	0.00106	CcSEcCtD
Levosimendan—Dizziness—Paclitaxel—breast cancer	0.000599	0.00104	CcSEcCtD
Levosimendan—Mental disorder—Doxorubicin—breast cancer	0.000591	0.00102	CcSEcCtD
Levosimendan—Malnutrition—Doxorubicin—breast cancer	0.000587	0.00102	CcSEcCtD
Levosimendan—Vomiting—Paclitaxel—breast cancer	0.000576	0.000996	CcSEcCtD
Levosimendan—Headache—Paclitaxel—breast cancer	0.000567	0.000982	CcSEcCtD
Levosimendan—Nervous system disorder—Methotrexate—breast cancer	0.000542	0.000939	CcSEcCtD
Levosimendan—Nausea—Paclitaxel—breast cancer	0.000538	0.000931	CcSEcCtD
Levosimendan—Diarrhoea—Docetaxel—breast cancer	0.000525	0.000909	CcSEcCtD
Levosimendan—Hypotension—Methotrexate—breast cancer	0.000517	0.000895	CcSEcCtD
Levosimendan—Diarrhoea—Capecitabine—breast cancer	0.000508	0.00088	CcSEcCtD
Levosimendan—Nervous system disorder—Epirubicin—breast cancer	0.000508	0.000879	CcSEcCtD
Levosimendan—Dizziness—Docetaxel—breast cancer	0.000508	0.000878	CcSEcCtD
Levosimendan—Tachycardia—Epirubicin—breast cancer	0.000505	0.000874	CcSEcCtD
Levosimendan—Insomnia—Methotrexate—breast cancer	0.0005	0.000866	CcSEcCtD
Levosimendan—Dizziness—Capecitabine—breast cancer	0.000491	0.00085	CcSEcCtD
Levosimendan—Vomiting—Docetaxel—breast cancer	0.000488	0.000844	CcSEcCtD
Levosimendan—Hypotension—Epirubicin—breast cancer	0.000484	0.000837	CcSEcCtD
Levosimendan—Headache—Docetaxel—breast cancer	0.000481	0.000832	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Methotrexate—breast cancer	0.000478	0.000826	CcSEcCtD
Levosimendan—Vomiting—Capecitabine—breast cancer	0.000472	0.000818	CcSEcCtD
Levosimendan—Nervous system disorder—Doxorubicin—breast cancer	0.00047	0.000813	CcSEcCtD
Levosimendan—Insomnia—Epirubicin—breast cancer	0.000468	0.00081	CcSEcCtD
Levosimendan—Tachycardia—Doxorubicin—breast cancer	0.000467	0.000809	CcSEcCtD
Levosimendan—Headache—Capecitabine—breast cancer	0.000466	0.000806	CcSEcCtD
Levosimendan—Nausea—Docetaxel—breast cancer	0.000456	0.000789	CcSEcCtD
Levosimendan—Hypotension—Doxorubicin—breast cancer	0.000448	0.000775	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Epirubicin—breast cancer	0.000447	0.000773	CcSEcCtD
Levosimendan—Constipation—Epirubicin—breast cancer	0.000443	0.000766	CcSEcCtD
Levosimendan—Nausea—Capecitabine—breast cancer	0.000441	0.000764	CcSEcCtD
Levosimendan—Insomnia—Doxorubicin—breast cancer	0.000433	0.00075	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000414	0.000716	CcSEcCtD
Levosimendan—Constipation—Doxorubicin—breast cancer	0.00041	0.000709	CcSEcCtD
Levosimendan—Diarrhoea—Methotrexate—breast cancer	0.000378	0.000655	CcSEcCtD
Levosimendan—Dizziness—Methotrexate—breast cancer	0.000366	0.000633	CcSEcCtD
Levosimendan—Diarrhoea—Epirubicin—breast cancer	0.000354	0.000613	CcSEcCtD
Levosimendan—Vomiting—Methotrexate—breast cancer	0.000352	0.000609	CcSEcCtD
Levosimendan—Headache—Methotrexate—breast cancer	0.000347	0.0006	CcSEcCtD
Levosimendan—Dizziness—Epirubicin—breast cancer	0.000342	0.000592	CcSEcCtD
Levosimendan—Vomiting—Epirubicin—breast cancer	0.000329	0.00057	CcSEcCtD
Levosimendan—Nausea—Methotrexate—breast cancer	0.000329	0.000569	CcSEcCtD
Levosimendan—Diarrhoea—Doxorubicin—breast cancer	0.000328	0.000567	CcSEcCtD
Levosimendan—Headache—Epirubicin—breast cancer	0.000324	0.000561	CcSEcCtD
Levosimendan—Dizziness—Doxorubicin—breast cancer	0.000317	0.000548	CcSEcCtD
Levosimendan—Nausea—Epirubicin—breast cancer	0.000307	0.000532	CcSEcCtD
Levosimendan—Vomiting—Doxorubicin—breast cancer	0.000305	0.000527	CcSEcCtD
Levosimendan—Headache—Doxorubicin—breast cancer	0.0003	0.000519	CcSEcCtD
Levosimendan—Nausea—Doxorubicin—breast cancer	0.000285	0.000492	CcSEcCtD
Levosimendan—PDE3A—Signaling by GPCR—EDNRB—breast cancer	0.000201	0.000853	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SFRP2—breast cancer	0.0002	0.000851	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MMP1—breast cancer	0.0002	0.00085	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRLR—breast cancer	0.000197	0.000836	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MDM2—breast cancer	0.000196	0.000835	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAU—breast cancer	0.000196	0.000834	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CDK2—breast cancer	0.000196	0.000834	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR4—breast cancer	0.000196	0.000834	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL12—breast cancer	0.000196	0.000834	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—RAF1—breast cancer	0.000196	0.000832	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARGC1B—breast cancer	0.000195	0.000829	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CAV1—breast cancer	0.000192	0.000815	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VCP—breast cancer	0.00019	0.000807	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GLI2—breast cancer	0.00019	0.000807	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEPR—breast cancer	0.000187	0.000794	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA4—breast cancer	0.000184	0.000783	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CA9—breast cancer	0.000184	0.000783	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FN1—breast cancer	0.000182	0.000776	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CALCA—breast cancer	0.000182	0.000775	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—breast cancer	0.00018	0.000767	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA2—breast cancer	0.000179	0.000763	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX2—breast cancer	0.000179	0.000763	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR4—breast cancer	0.000178	0.000757	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL12—breast cancer	0.000178	0.000757	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGTR1—breast cancer	0.000177	0.000754	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX4—breast cancer	0.000177	0.000754	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SULT1A1—breast cancer	0.000177	0.000754	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CG—breast cancer	0.000175	0.000742	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ARHGDIA—breast cancer	0.000174	0.000738	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA1—breast cancer	0.000173	0.000736	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—IDH1—breast cancer	0.000173	0.000736	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EGF—breast cancer	0.000173	0.000734	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NAT2—breast cancer	0.000171	0.000728	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FST—breast cancer	0.000169	0.000719	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HEY2—breast cancer	0.000167	0.000711	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RPS6KB2—breast cancer	0.000165	0.000702	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RGS2—breast cancer	0.000163	0.000694	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL20—breast cancer	0.000161	0.000686	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGTR1—breast cancer	0.000161	0.000685	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—breast cancer	0.00016	0.00068	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT2—breast cancer	0.00016	0.000679	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ITPR1—breast cancer	0.000159	0.000677	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TLE3—breast cancer	0.000156	0.000665	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LPAR1—breast cancer	0.000156	0.000665	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HEY1—breast cancer	0.000155	0.000658	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CD—breast cancer	0.000153	0.000653	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE1—breast cancer	0.000152	0.000646	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DLL1—breast cancer	0.000152	0.000645	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—breast cancer	0.000152	0.000644	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MED12—breast cancer	0.00015	0.000638	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—DPYD—breast cancer	0.00015	0.000638	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIST1H2BC—breast cancer	0.000149	0.000633	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIST1H2BK—breast cancer	0.000149	0.000633	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDOA—breast cancer	0.000148	0.000628	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GRB7—breast cancer	0.000148	0.000628	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDE4D—breast cancer	0.000148	0.000628	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CSF2—breast cancer	0.000147	0.000625	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TAB2—breast cancer	0.000145	0.000617	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—breast cancer	0.000145	0.000616	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ITPR1—breast cancer	0.000144	0.000614	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CNR2—breast cancer	0.000144	0.000612	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MMP3—breast cancer	0.000144	0.00061	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA3—breast cancer	0.000143	0.00061	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC2A2—breast cancer	0.000142	0.000606	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DKK1—breast cancer	0.00014	0.000597	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCG2—breast cancer	0.00014	0.000593	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CPT1A—breast cancer	0.00014	0.000593	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTR—breast cancer	0.00014	0.000593	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFC—breast cancer	0.000139	0.000592	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAG2—breast cancer	0.000137	0.000584	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RAF1—breast cancer	0.000137	0.000583	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HPGDS—breast cancer	0.000137	0.000582	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HBA1—breast cancer	0.000136	0.000578	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—WNT1—breast cancer	0.000135	0.000575	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PLA2G4A—breast cancer	0.000135	0.000574	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CB—breast cancer	0.000134	0.000569	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CSF2—breast cancer	0.000133	0.000567	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ACHE—breast cancer	0.000133	0.000564	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—breast cancer	0.000133	0.000564	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH4—breast cancer	0.000128	0.000545	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GZMB—breast cancer	0.000127	0.000542	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP17A1—breast cancer	0.000126	0.000534	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ENO1—breast cancer	0.000124	0.000529	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS1—breast cancer	0.000124	0.000529	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR2—breast cancer	0.000124	0.000526	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL2—breast cancer	0.000124	0.000526	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2—breast cancer	0.000123	0.000522	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BMP2—breast cancer	0.000122	0.00052	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTHLH—breast cancer	0.000122	0.00052	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2D6—breast cancer	0.000122	0.000519	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA2—breast cancer	0.00012	0.000509	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDNRB—breast cancer	0.000118	0.000504	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PGR—breast cancer	0.000117	0.000499	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—THBS1—breast cancer	0.000117	0.000496	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—FASN—breast cancer	0.000116	0.000494	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—BCHE—breast cancer	0.000116	0.000492	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC5A5—breast cancer	0.000114	0.000486	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FLT1—breast cancer	0.000111	0.000474	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SQSTM1—breast cancer	0.000111	0.000472	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF3—breast cancer	0.000111	0.000472	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CG—breast cancer	0.00011	0.000469	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NQO1—breast cancer	0.00011	0.000469	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC2A1—breast cancer	0.00011	0.000469	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAG1—breast cancer	0.000109	0.000466	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH3—breast cancer	0.000109	0.000464	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PARP1—breast cancer	0.000109	0.000464	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—HRAS—breast cancer	0.000108	0.000458	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CALCA—breast cancer	0.000108	0.000458	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP3A4—breast cancer	0.000108	0.000457	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SRC—breast cancer	0.000107	0.000456	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RPS6—breast cancer	0.000106	0.000452	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1B1—breast cancer	0.000106	0.00045	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF4—breast cancer	0.000106	0.000449	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR4—breast cancer	0.000105	0.000447	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL12—breast cancer	0.000105	0.000447	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—breast cancer	0.000104	0.000444	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HSP90AA1—breast cancer	0.000104	0.000441	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PAK1—breast cancer	0.000103	0.000439	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TCF7L2—breast cancer	0.000101	0.000431	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT2—breast cancer	0.000101	0.000429	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOA1—breast cancer	0.000101	0.000429	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CG—breast cancer	0.0001	0.000426	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP19A1—breast cancer	9.94e-05	0.000423	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—STK11—breast cancer	9.94e-05	0.000423	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK3—breast cancer	9.88e-05	0.00042	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HSP90AA1—breast cancer	9.78e-05	0.000416	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH2—breast cancer	9.78e-05	0.000416	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CD—breast cancer	9.7e-05	0.000412	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—breast cancer	9.58e-05	0.000408	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRL—breast cancer	9.51e-05	0.000404	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR1—breast cancer	9.51e-05	0.000404	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STK11—breast cancer	9.37e-05	0.000399	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADAM10—breast cancer	9.37e-05	0.000399	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLG—breast cancer	9.27e-05	0.000394	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—COMT—breast cancer	9.24e-05	0.000393	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—breast cancer	9.2e-05	0.000391	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT2—breast cancer	9.17e-05	0.00039	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF10—breast cancer	9.12e-05	0.000388	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—breast cancer	9.07e-05	0.000386	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ITPR1—breast cancer	9.05e-05	0.000385	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—breast cancer	8.88e-05	0.000377	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CD—breast cancer	8.81e-05	0.000375	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFA—breast cancer	8.8e-05	0.000374	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCB1—breast cancer	8.71e-05	0.00037	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFBR2—breast cancer	8.67e-05	0.000369	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TYMS—breast cancer	8.55e-05	0.000364	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITPR1—breast cancer	8.54e-05	0.000363	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB4—breast cancer	8.48e-05	0.000361	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT5A—breast cancer	8.48e-05	0.000361	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP3—breast cancer	8.48e-05	0.000361	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOR1—breast cancer	8.45e-05	0.00036	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLA2G4A—breast cancer	8.45e-05	0.00036	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—breast cancer	8.45e-05	0.00036	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CB—breast cancer	8.45e-05	0.00036	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SMAD4—breast cancer	8.21e-05	0.000349	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1R—breast cancer	8.16e-05	0.000347	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—breast cancer	8.15e-05	0.000347	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—breast cancer	8.12e-05	0.000345	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX1—breast cancer	8.1e-05	0.000344	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HES1—breast cancer	8.02e-05	0.000341	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP1A1—breast cancer	8.01e-05	0.000341	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLA2G4A—breast cancer	7.97e-05	0.000339	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NCOR1—breast cancer	7.97e-05	0.000339	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ERCC2—breast cancer	7.95e-05	0.000338	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—breast cancer	7.89e-05	0.000335	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF1—breast cancer	7.88e-05	0.000335	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CSF2—breast cancer	7.88e-05	0.000335	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAF1—breast cancer	7.86e-05	0.000334	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NRG1—breast cancer	7.82e-05	0.000333	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—H2AFX—breast cancer	7.77e-05	0.00033	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2—breast cancer	7.76e-05	0.00033	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—E2F1—breast cancer	7.71e-05	0.000328	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CB—breast cancer	7.68e-05	0.000326	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HRAS—breast cancer	7.54e-05	0.000321	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—breast cancer	7.47e-05	0.000318	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SPP1—breast cancer	7.41e-05	0.000315	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—breast cancer	7.38e-05	0.000314	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB3—breast cancer	7.33e-05	0.000312	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR2—breast cancer	7.32e-05	0.000311	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2—breast cancer	7.05e-05	0.0003	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TERT—breast cancer	7.02e-05	0.000299	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAV1—breast cancer	6.89e-05	0.000293	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR1—breast cancer	6.82e-05	0.00029	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—breast cancer	6.72e-05	0.000286	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—breast cancer	6.66e-05	0.000283	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—breast cancer	6.56e-05	0.000279	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CAV1—breast cancer	6.5e-05	0.000276	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—breast cancer	6.43e-05	0.000273	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CG—breast cancer	6.28e-05	0.000267	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ESR1—breast cancer	6.26e-05	0.000266	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FN1—breast cancer	6.18e-05	0.000263	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NFKBIA—breast cancer	6.11e-05	0.00026	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH1—breast cancer	6.05e-05	0.000257	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CG—breast cancer	5.92e-05	0.000252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KIT—breast cancer	5.92e-05	0.000252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APC—breast cancer	5.92e-05	0.000252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGF—breast cancer	5.85e-05	0.000249	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK3—breast cancer	5.67e-05	0.000241	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BRAF—breast cancer	5.56e-05	0.000237	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CD—breast cancer	5.52e-05	0.000235	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—breast cancer	5.45e-05	0.000232	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—breast cancer	5.42e-05	0.00023	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT2—breast cancer	5.42e-05	0.00023	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—breast cancer	5.39e-05	0.000229	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—breast cancer	5.21e-05	0.000222	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CD—breast cancer	5.2e-05	0.000221	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—breast cancer	5.15e-05	0.000219	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SERPINE1—breast cancer	5.15e-05	0.000219	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—breast cancer	5.09e-05	0.000217	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—breast cancer	4.91e-05	0.000209	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CB—breast cancer	4.81e-05	0.000205	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—breast cancer	4.77e-05	0.000203	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—breast cancer	4.68e-05	0.000199	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MDM2—breast cancer	4.66e-05	0.000198	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAF1—breast cancer	4.65e-05	0.000198	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RELA—breast cancer	4.62e-05	0.000197	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB2—breast cancer	4.6e-05	0.000195	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MTOR—breast cancer	4.54e-05	0.000193	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CB—breast cancer	4.54e-05	0.000193	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—breast cancer	4.36e-05	0.000185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HRAS—breast cancer	4.33e-05	0.000184	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1B—breast cancer	4.26e-05	0.000181	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—breast cancer	4.21e-05	0.000179	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—breast cancer	4.17e-05	0.000177	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2—breast cancer	4.17e-05	0.000177	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTEN—breast cancer	4.16e-05	0.000177	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—breast cancer	4.14e-05	0.000176	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—breast cancer	4.06e-05	0.000173	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JUN—breast cancer	4.05e-05	0.000172	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CTNNB1—breast cancer	4.02e-05	0.000171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—breast cancer	3.94e-05	0.000168	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN1A—breast cancer	3.93e-05	0.000167	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTEN—breast cancer	3.92e-05	0.000167	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK8—breast cancer	3.83e-05	0.000163	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—breast cancer	3.82e-05	0.000163	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SRC—breast cancer	3.63e-05	0.000155	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—breast cancer	3.54e-05	0.000151	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—breast cancer	3.5e-05	0.000149	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK3—breast cancer	3.35e-05	0.000142	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—breast cancer	3.26e-05	0.000138	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—breast cancer	3.25e-05	0.000138	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—breast cancer	3.19e-05	0.000135	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—breast cancer	3.01e-05	0.000128	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—breast cancer	2.93e-05	0.000125	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—breast cancer	2.76e-05	0.000118	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—breast cancer	2.67e-05	0.000114	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HRAS—breast cancer	2.56e-05	0.000109	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—breast cancer	2.45e-05	0.000104	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—breast cancer	2.4e-05	0.000102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—breast cancer	2.26e-05	9.6e-05	CbGpPWpGaD
